Stay updated on SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.

Latest updates to the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing Revision: v3.3.2, as well as deleting the HHS Vulnerability Disclosure link. The study details page content remains unchanged.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe change represents a minor revision update from v3.2.0 to v3.3.2 with no visible edits to study details, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding lapse and operating status notice banner was removed from the page.SummaryDifference0.4%

- Check63 days agoChange DetectedSubstantial content remains unchanged: the study title, eligibility criteria, endpoints, and locations are the same. Any observed differences are minor layout or styling adjustments.SummaryDifference0.4%

- Check91 days agoChange Detected- Added a government-operating-status notice and operating details for the NIH Clinical Center; - Updated version from v3.1.0 to v3.2.0; - Removed the old v3.1.0 reference.SummaryDifference3%

- Check98 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.1%

Stay in the know with updates to SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.